UA19318A - Method for human mno2-dismutase obtaining - Google Patents

Method for human mno2-dismutase obtaining

Info

Publication number
UA19318A
UA19318A UA4355336A UA4355336A UA19318A UA 19318 A UA19318 A UA 19318A UA 4355336 A UA4355336 A UA 4355336A UA 4355336 A UA4355336 A UA 4355336A UA 19318 A UA19318 A UA 19318A
Authority
UA
Ukraine
Prior art keywords
dismutase
obtaining
human
mno2
kdna
Prior art date
Application number
UA4355336A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Хекль Конрад
Спевак Вальтер
Остерманн Елінборг
Цефель Андреас
Кристек Едельтрауд
Маурер-Фогі Інгрід
Йозефа Віхе-Кастанон Марія
Стратова Крістіан
Гауптманн Рудольф
Original Assignee
Берінгер Інгельгейм Інтернаціональ Гмбх
Берингер Ингельгейм Интернациональ ГмбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берінгер Інгельгейм Інтернаціональ Гмбх, Берингер Ингельгейм Интернациональ ГмбХ filed Critical Берінгер Інгельгейм Інтернаціональ Гмбх
Publication of UA19318A publication Critical patent/UA19318A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/07—Fusion polypeptide containing a localisation/targetting motif containing a mitochondrial localisation signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention relates to biotechnology and genetic engineering, in particular, tp methods for obtaining of human MnO2-dismutase for therapeutic use, e.g., as anti-inflammatory agent. A method comprises the isolation of mRNA from placental or hepatic human tissues, obtaining of poly (A)+RNA, synthesizing of two-stranded kDNA, construction of kDNA bank, isolation of DNA sequence and coding of Mn2O-dismutase.
UA4355336A 1987-03-14 1988-03-14 Method for human mno2-dismutase obtaining UA19318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873708306 DE3708306A1 (en) 1987-03-14 1987-03-14 Human manganese superoxide dismutase (hMn-SOD)

Publications (1)

Publication Number Publication Date
UA19318A true UA19318A (en) 1997-12-25

Family

ID=6323067

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4355336A UA19318A (en) 1987-03-14 1988-03-14 Method for human mno2-dismutase obtaining

Country Status (4)

Country Link
DE (1) DE3708306A1 (en)
SU (1) SU1741610A3 (en)
UA (1) UA19318A (en)
ZA (1) ZA881743B (en)

Also Published As

Publication number Publication date
ZA881743B (en) 1989-11-29
SU1741610A3 (en) 1992-06-15
DE3708306A1 (en) 1988-09-22

Similar Documents

Publication Publication Date Title
ATE174599T1 (en) BINDING COMPETENT OLIGOMERS CONTAINING 2',5' BONDS
DK0910647T3 (en) Human DNase in hyperactive variants
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
WO1999054461A3 (en) Human nucleic acid sequences of endometrium tumour tissue
AU637354B2 (en) Genetic units for inhibiting the function of rna
PT1053313E (en) OLIGONUCLEOTIDOS '' ANTISENSE '' OPTIMIZED COMPLEMENTARY SEQUENCES OF DNA METHYLTRANSFERASE
MY134810A (en) Targeted gene expression of thrombopoietein, dnase i and b-interferon
WO1996034953A3 (en) Cd16-ii variants
MXPA03002413A (en) B7-like molecules and uses thereof.
EP0088195A3 (en) Messenger rna, production and use thereof
HUP0103465A2 (en) Short oligonucleotides for the inhibition of vegf expression
AU8881201A (en) Tnf receptor-like molecules and uses thereof
DK1175489T3 (en) Oligonucleotides containing an antisense sequence stabilized by a secondary structure and pharmaceutical preparations containing these oligonucleotides
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
WO1998054313A3 (en) Dna methyltransferase genomic sequences and antisense oligonucleotides
DE69736276D1 (en) HUMAN DNASE RESISTANT AGAINST ACTININHIBITORS
ATE371031T1 (en) HERPES SIMPLEX VIRUS EXPRESSING THE INTERLEUKIN-12 GENE AND ITS USE IN THE TREATMENT OF CANCER
WO1999054353A3 (en) Human nucleic acid sequences of normal uterus tissue
WO1999054447A3 (en) Human nucleic acid sequences of bladder tumour tissue
MXPA02000680A (en) Vgf polypeptides and methods of treating vgf-related disorders.
UA19318A (en) Method for human mno2-dismutase obtaining
DE69730967D1 (en) Human dnase ii
WO1999054448A3 (en) Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
CA2242562A1 (en) Human dnase resistant to actin inhibition
WO1998006440A3 (en) Phenotypic conversion of cells mediated by external guide sequences